Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol

Background: The Coronavirus disease (COVID-19) pandemic is causing millions of infections and hundreds of thousands of deaths worldwide. Cumulative clinical and laboratory evidence suggest that a subset of patients with severe COVID-19 may develop a cytokine storm syndrome during the course of the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Capochiani, Enrico, Frediani, Bruno, Iervasi, Giorgio, Paolicchi, Aldo, Sani, Spartaco, Roncucci, Paolo, Cuccaro, Annarosa, Franchi, Federico, Simonetti, Federico, Carrara, Davide, Bertaggia, Ilaria, Nasso, Daniela, Riccioni, Rossella, Scolletta, Sabino, Valente, Serafina, Conticini, Edoardo, Gozzetti, Alessandro, Bocchia, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417512/
https://www.ncbi.nlm.nih.gov/pubmed/32850921
http://dx.doi.org/10.3389/fmed.2020.00466

Ejemplares similares

Ejemplares similares